Watchlist Price Alert

Taisho Pharmaceutical Co... (TAIPY)

PNK: TAIPY · Real-Time Price · USD

14.00

null (null%)

At close: Jul 12, 2024, 8:00 PM

Taisho Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	301.38B	268.2B	282.04B	288.72B	261.37B	280.14B	279.75B	289.96B
Cost of Revenue	123.53B	104.37B	106.05B	108.34B	91.21B	97.15B	101.53B	113.14B
Gross Profit	177.85B	163.83B	175.99B	180.38B	170.16B	182.98B	178.22B	176.81B
Operating Income	23.02B	10.74B	19.96B	21.46B	31.21B	36.98B	31.97B	28.88B
Interest Income	1.59B	1.34B	1.69B	3.77B	4.95B	5B	5.13B	5.39B
Pretax Income	29.5B	21.4B	22.98B	30.31B	64.48B	48.07B	41.96B	35.81B
Net Income	19B	13.12B	13.32B	20.17B	48.59B	31.68B	28.78B	22.47B
Selling & General & Admin	134.1B	133.72B	135.77B	136.32B	118.15B	n/a	n/a	n/a
Research & Development	20.73B	19.37B	20.25B	22.88B	20.8B	n/a	n/a	n/a
Other Expenses	322M	-136M	335M	170M	1.1B	634M	606M	686M
Operating Expenses	154.83B	153.09B	156.02B	158.92B	138.95B	146.01B	146.26B	147.94B
Interest Expense	169M	170M	156M	118M	2M	2M	1M	2M
Selling & Marketing Expenses	49.46B	51.4B	57.39B	61.55B	55.03B	n/a	n/a	n/a
Cost & Expenses	278.36B	257.46B	262.07B	267.26B	230.16B	243.16B	247.78B	261.08B
Income Tax Expense	8.2B	6.45B	7.78B	8.42B	14.66B	14.7B	11.75B	11.93B
Shares Outstanding (Basic)	81.98M	81.44M	79.82M	79.81M	319.27M	319.56M	319.63M	323.64M
Shares Outstanding (Diluted)	82.09M	81.54M	79.91M	79.9M	319.58M	319.83M	319.86M	323.83M
EPS (Basic)	231.72	161.12	166.83	252.73	152.20	99.13	90.05	69.44
EPS (Diluted)	231.42	160.93	166.63	252.44	152.05	99.05	89.98	69.40
EBITDA	54.31B	44.64B	45.17B	41.82B	52.14B	59.45B	53.63B	41.35B
EBIT	29.67B	21.57B	23.13B	29.89B	64.49B	48.07B	41.96B	35.81B
Depreciation & Amortization	24.65B	24.65B	23.07B	22.04B	16.7B	11.29B	11.38B	11.67B